1. Read the current label
Enter the total PT-141 amount printed on the vial and the total liquid volume for that same vial. Do not combine values from two products.
PT-141 is a common name associated with bremelanotide, but product format matters. This guide is not for the FDA-approved Vyleesi single-dose autoinjector and does not recommend bremelanotide use or dosing.
Illustrative arithmetic · not dosing guidance
Every row is arithmetic based on 5 mg in 2 mL, producing a concentration of 2.5 mg/mL. This is not a mixing instruction. The target values are mathematical examples. They are not common, prescribed, or recommended doses.
| Example target | Volume at 2.5 mg/mL | U-100 marking |
|---|---|---|
| 0.5 mg | 0.2 mL | 20 units |
| 1 mg | 0.4 mL | 40 units |
| 2 mg | 0.8 mL | 80 units |
Do not convert or transfer an autoinjector dose. Use this page only when a licensed professional has supplied a vial with explicit mass, concentration, and syringe instructions.
Three-step calculation
This page explains the calculation. The shared Peptide Calculator applies values you already have and never chooses a vial amount, liquid volume, target mass, or schedule.
Enter the total PT-141 amount printed on the vial and the total liquid volume for that same vial. Do not combine values from two products.
Use the CTA above to preselect PT-141, then replace every illustrative value with the vial, liquid, and target values from your qualified source.
Read concentration first, then mL, then the U-100 marking. Repeat the decimal and unit conversion independently before relying on the result.
Product-specific context
PT-141 is widely used as a shorthand name for bremelanotide. Vyleesi is an FDA-approved bremelanotide product supplied as a single-dose disposable autoinjector, not a user-reconstituted multi-dose vial.
The approved product has specific indications, contraindications, warnings, and Instructions for Use. A generic PT-141 dosage calculator cannot decide whether those criteria are met and should never be used to alter an autoinjector.
If a licensed prescriber and pharmacy provide a different vial formulation, its exact label controls the arithmetic. The mg/mL concentration and prescribed target must be entered from that source; neither can be inferred from the Vyleesi device or an online protocol.
Transparent arithmetic
The name does not change the equations. Concentration links mass to volume; the U-100 conversion is applied last.
vial mg ÷ liquid mL = mg/mLtarget mg ÷ mg/mL = mLdose mL × 100 = unitsIf the target is entered in mcg, divide by 1,000 before using the dose-volume formula. The linked calculator does this conversion internally while keeping both mass units visible in the result.
Before accepting a result
The approved Vyleesi autoinjector delivers a fixed labeled presentation and should not be converted with vial math.
A compounded PT-141 vial is not the same finished product as FDA-approved Vyleesi.
A calculator cannot screen cardiovascular history, medication interactions, pregnancy, or other clinical factors.
Common questions
Continue with a specific intent
Each peptide has its own landing page and product context. Calculator formulas may be shared, but labels and regulatory boundaries are not interchangeable.
This page performs mathematical conversions only. It does not recommend PT-141, provide a dose or protocol, verify a product, establish sterility or compatibility, or replace instructions from a licensed prescriber or pharmacist.
Read the full disclaimer